Florida Blue Launches Oncology ACO
In the beginning, an estimated 500 to 1,000 of Blue Florida's commercial members are expected to be part of the ACO. There are plans to expand the program to its Medicare Advantage members in South Florida.
The ACO will look at clinical outcomes tied to readmission rates, adherence to chemotherapy regimens, and adherence to accepted clinical guidelines as well as the efficiency of care delivered to the patient.
Gavras declined to discuss the financial arrangements for the ACO but said the upfront costs include analytics. "This is a data intensive process. The amount of data and information that has to be pulled together and gone through is enormous. This is not easy stuff." Florida Blue will provide much of the data analysis. AMS will maintain the electronic medical records.
The Unsettled State of the ACO
Margaret Dick Tocknell is a reporter/editor with HealthLeaders Media.
- Providers Lag as Consumers Set Agenda
- Look Beyond Nurse-Patient Ratios
- Esther Dyson Launches Population Health Challenge
- Crisis Spurs Healthcare Payment Reform in Arkansas
- ICD-10 Delay Alters Provider, Vendor Prep
- Reform Puts Vise Grips on Physicians
- Hospital Groups Back NQF Report on Patient Sociodemographics
- Payment Reform Naysayers 'Better Wake Up'
- NPP Demand Rising Under Value-Based Care Models
- Reduce Readmissions by Activating Patients to Do 'Self-Care'